AMLX (amylyx.com) Prakiraan pendapatan perusahaan

Amylyx Pharmaceuticals Inc - logo grafis emiten AMLX

High risks and fierce competition with market behemoths are weighing on the credit profile of Amylyx Pharmaceuticals (AMLX). The projected sales trajectory for products contained within the GURU.Markets platform demonstrates volatility, where 0.00 serves as the final level mark. Financial stability currently relies on the search for new molecules to treat Wolfram syndrome, which is intended to mitigate the fallout from the reputational collapse following the recall of the primary drug.

AMLX - Pendapatan mangsa ngarep perusahaan Amylyx Corp ing rentang 04.07.2022 - 16.11.2026

Rincian metrik keuangan lan pasar Amylyx Corp (AMLX)

- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:amylyx.com
Produk mawa merek Amylyx

Effective diversification of distribution channels for Amylyx Pharmaceuticals (AMLX) neurological drugs guarantees a stable revenue stream and high margins even during market disruptions. An analysis of the firm's sales volume benchmarks allows for an assessment of the business's fundamental resilience amid turbulence, where daily monitoring of risk mandate deviations helps investors classify the asset by reliability level and avoid impulsive decisions.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan TRVI (Trevi Corp)|Dodolan mangsa ngarep perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Prakiraan volume dodolan|CeriBell Corp (CBLL) - Volume dodolan mangsa ngarep perusahaan|Prothena Corp (PRTA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alector Inc. (ALEC)|Volume dodolan mangsa ngarep perusahaan ANNX|omeros.com (OMER) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VYGR (voyagertherapeutics.com)|Dodolan mangsa ngarep perusahaan Neumora Therapeutics (NMRA)|SCLX - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Prakiraan pendapatan perusahaan|CGTX - Dodolan mangsa ngarep perusahaan|IKT (inhibikase.com) - Prakiraan volume dodolan|cassavasciences.com (SAVA) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan ASRT (Assertio Therapeutics)|Dodolan mangsa ngarep perusahaan Coya Therapeutics|Vistagen - Volume dodolan mangsa ngarep perusahaan|ovidrx.com (OVID) - Volume dodolan sing dikarepake perusahaan|Acumen Pharmaceuticals - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan cervomed.com|ATHE: Prakiraan volume dodolan|Clene Inc - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Prakiraan volume pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan RLMD (Relmada Corp)|annovisbio.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan sing dikarepake perusahaan|KLTO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics